BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹386 Cr | ₹1,013 Cr | ₹1,023 Cr | ₹463 Cr | ₹648 Cr |
What is the latest Consolidated Net Profit of BIOCON ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹386 Cr |
| Mar2025 | ₹1,013 Cr |
| Mar2024 | ₹1,023 Cr |
| Mar2023 | ₹463 Cr |
| Mar2022 | ₹648 Cr |
How is Consolidated Net Profit of BIOCON Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹386 Cr | -61.95 | |
| Mar2025 | ₹1,013 Cr | -0.90 | |
| Mar2024 | ₹1,023 Cr | 120.99 | |
| Mar2023 | ₹463 Cr | -28.64 | |
| Mar2022 | ₹648 Cr | - | |
Compare Consolidated Net Profit of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹70,215.6 Cr | -1% | 3% | 11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1% |
3% |
11.7% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses